Therapeutic update of severe pulmonary hypertension in COPD

A. Chaouat (Vandoeuvre-Les-Nancy, France)

Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD
Session: Pulmonary vascular involvement in COPD
Session type: Symposium
Number: 3605
Disease area: Pulmonary vascular diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Chaouat (Vandoeuvre-Les-Nancy, France). Therapeutic update of severe pulmonary hypertension in COPD. Annual Congress 2010 - Pulmonary vascular involvement in COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Which treatment for which patient with an acute exacerbation of pulmonary hypertension?
Source: Annual Congress 2010 - The acute right heart syndrome in the intensive care unit: a hidden world?
Year: 2010

Current management of patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010

Imaging in assessment of out-of-proportion pulmonary hypertension in patients with COPD
Source: Annual Congress 2010 - Parenchmya and bronchial carcinoma
Year: 2010


Oxygen therapy decreases systemic inflammation in patients with chronic obstructive pulmonary disease and hypoxemia
Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease
Year: 2010


Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014


Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014


Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Adherence with inhaled respiratory therapeutics is associated with reduced acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011


Comparison pulmonary rehabilitation efficiency in COPD patients between with and without pulmonary hypertension
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014

Clinical usefulness of end-tidal CO2 profiles during rapidly-incremental exercise in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013

COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014

Comparing cardiopulmonary responses to incremental exercise in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Altered mechanisms during exercise in disease
Year: 2011


Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015



Characteristics of pulmonary function of COPD with and without arterial pulmonary hypertension
Source: International Congress 2014 – Comorbidities
Year: 2014

Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 427s
Year: 2003

Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005